|
1. Sedighe M, Gholamhossein G. Thyroid dysfunction and thyroid antibodies in Iranian patients with vitiligo. Indian J Dermatol. 2008;53(1): 9-11. doi:10.4103/0019-5154.39733 2. Singh S, Singh U, Pandy SS. Thyroid dysfunction and anti-thyroid peroxidase antibody in patients with vitiligo. Int J Pharm Biol Arch. 2011; 2(3): 891-95. 3. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 2003 Jun; 16(3): 208-14. 4. Osman AM, Mirghani YA. Thyroid dysfunctions in sudanese patients with vitiligo. Sudan JMS. 2010; 5(1): 25-29. 5. Sandoval-Cruz M, García-Carrasco M, Sánchez-Porras R, Mendoza-Pinto C, Jiménez-Hernández M, Munguía-Realpozo P, et al. Immunopathogenesis of vitiligo. Autoimmun Rev. 2011 Oct; 10(12): 762-5. doi:10.1016/j.autrev.2011.02.004 6. Ziaul Amin Md, Hafizur Rahman M, Hassan P. Thyroid function in Bangladeshi patients with Vitiligo (Sheti). J Bio-Sci. 2008; 16:101-3. doi:10.3329/jbs.v16i0.3749 7. Iacovelli P, Sinagra JL, Vidolin AP, Marenda S, Capitanio B, Leone G, et al. Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology. 2005; 210(1): 26-30. 8. Rezaei N, Gavalas NG, Weetman AP, Kemp EH. Autoimmunity as an aetiological factor in vitiligo. J Eur Acad Dermatol Venereol. 2007 Aug; 21(7): 865-76. 9. Ongenae K, Van Geel N, Naeyaert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res. 2003 Apr; 16(2): 90-100. 10. Daneshpazhooh M, Mostofizadeh G M, Behjati J, Akhyani M, Robati RM. Anti-thyroid peroxidase antibody and vitiligo: a controlled study. BMC Dermatol. 2006 Mar; 6:3. 11. Uncu S, Yaylı S, Bahadır S, Okten A, Alpay K. Relevance of autoimmune thyroiditis in children and adolescents with vitiligo. Int J Dermatol. 2011 Feb; 50(2): 175-9. doi:10.1111/j.1365-4632.2010.04665.x 12. Zettinig G, Tanew A, Fischer G, Mayr W, Dudczak R, Weissel M. Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume? Clin Exp Immunol. 2003 Feb; 131(2): 347-54. 13. Altaf H, Shah IH, Ahmad QM. Evaluation of thyroid function and presence of antithyroid peroxidase antibodies in patients with vitiligo. Egyptian Dermatol Online J. 2010; 6(1): 3. 14. Zamanian A, Mobasher P, Ansar A, Manuchehri S, Jazi GA. Autoimmune thyroid disorders in patients with vitiligo. Journal of Skin and Stem Cell. 2014; 1(12): e22113. doi:10.17795/jssc22113 15. Majumder PP, Nordlund JJ, Nath SK. Pattern of familial aggregation of vitiligo. Arch Dermatol. 1993 Aug; 129(8): 994-8. 16. Fernandes NC, Campos MM. Childhood vitiligo and thyroid disease. An Bras Dermatol. 2009 Mar-Apr; 84(2): 200-2. [Article in English, Portuguese] 17. Kumar V, Shankar V, Chaudhary S, Bhatia KK, Mehta LK, Arora N, et al. Radio-active iodine uptake in vitiligo. J Dermatol. 1990 Jan; 17(1): 41-3. 18. Kasumagic-Halilovic E, Prohic A, Begovic B, Ovcina-Kurtovic N. Association between vitiligo and thyroid autoimmunity. Journal of Thyroid Research. 2011; (2011): Article ID 938257, 3 pages. http://dx.doi.org/10.4061/2011/938257 19. Zamanian A, Mobasher P, Ansar A, Manuchehri S, Ahmadi Jazi G. Autoimmune thyroid disorders in patients with vitiligo. J Skin Stem Cell. 2014 Oct; 1(2): e22113. doi:10.17795/jssc22113 20. Arýcan O, Koç K, Ersoy L. Clinical characteristics in 113 Turkish vitiligo patients. Acta Dermatovenerol Alp Pannonica Adriat. 2008 Sep; 17(3): 129-32. 21. Kmet J, Mahboubi E. Esophageal cancer in the Caspian littoral of Iran: initial studies. Science. 1972 Feb; 175(4024): 846-53. 22. Dave S, D'Souza M, Thappa DM, Reddy KS, Bobby ZB. High frequency of thyroid dysfunction in Indian patients with vitiligo. Indian Journal of Dermatology. 2003; 48(2): 68-72. 23. Daneshpazhooh M, Mostofizadeh G M, Behjati J, Akhyani M, Robati RM. Anti-thyroid peroxidase antibody and vitiligo: a controlled study. BMC Dermatology. 2006; 6:3. doi:10.1186/1471-5945-6-3
|
